Skip to main content
OCS logo

Oculis Holding AG

OCSNASDAQHealthcareBiotechnology

$7.90Today:- (-)1Y −62.11%

As of Oct 23, 2026 close

Market cap
$484.04M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$7.11$34.48
Volume (live)
-
Avg. volume (3M)
309.90K

Oculis Holding (OCS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Oculis Holding used CHF 66.30M of cash in operating activities and spent CHF 301.00K on capital expenditures. That left free cash flow of −CHF 66.61M.

Oculis Holding Cash Flow Statement Analysis

Values in millions CHF

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Oculis Holding AG (OCS) - Annual data in millions CHF
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-99.14-85.94-88.70-38.64-18.52-14.79
Depreciation & Amortization0.550.410.290.300.240.23
Deferred Income Tax0.000.000.000.000.000.05
Stock Based Compensation16.049.783.610.801.200.33
Change in Working Capital-0.0714.16-12.996.00-0.79-0.45
Change in Accounts Receivable-0.360.250.04-0.150.230.01
Change in Inventory0.000.000.000.000.00-0.01
Change in Accounts Payable-1.959.41-7.443.040.03-0.65
Change in Other Working Capital2.184.3639.603.11-0.820.20
Other Operating Activities16.3812.8239.606.474.172.61
Net Cash from Operating Activities-66.30-48.92-55.04-25.07-13.83-12.03
Investing Activities
Capital Expenditures-0.30-0.23-0.05-3.55-0.03-0.02
Purchases of Investments-60.79-17.33-54.160.000.000.00
Sales/Maturities of Investments-1.090.000.000.000.000.00
Other Investing Activities1.241.470.00-3.480.000.00
Net Cash from Investing Activities-60.93-16.08-52.97-3.55-0.03-0.02
Financing Activities
Debt Repayment-0.37-0.27-0.16-0.16-0.10-0.10
Common Stock Issued200.6057.20135.620.000.000.00
Other Financing Activities-13.31-2.95-7.591.87-0.804.96
Net Cash from Financing Activities186.9253.98129.631.7155.194.86
Summary
Effect of Forex Changes on Cash0.170.41-3.080.42-0.02-0.01
Net Change in Cash53.62-10.6221.62-26.4941.33-7.20
Cash at Beginning of Period24.2538.3319.7946.284.9512.15
Cash at End of Period81.4227.7138.3319.7946.284.95
Free Cash Flow-66.61-49.15-55.09-28.62-13.85-12.05
Supplemental Disclosures
Interest Paid0.090.050.050.100.120.06
Income Taxes Paid0.060.150.100.02--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Oculis Holding Cash Flow

What is Oculis Holding's free cash flow?

Oculis Holding had negative free cash flow of CHF 66.61M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −CHF 66.30M minus CHF 301.00K of capital expenditures.

How much does Oculis Holding spend on capital expenditures?

Oculis Holding spent CHF 301.00K on capital expenditures in fiscal 2025, compared with CHF 230.00K a year earlier.

Does Oculis Holding pay dividends or buy back shares?

Oculis Holding's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition